Mahmut Ilker Yilmaz1, Alper Sonmez2, Mutlu Saglam3, Tuncer Cayci4, Selim Kilic5, Hilmi Umut Unal6, Murat Karaman6, Hakki Cetinkaya6, Tayfun Eyileten6, Mahmut Gok6, Yusuf Oguz6, Abdulgaffar Vural6, Francesca Mallamaci7, Carmine Zoccali8. 1. Departments of Nephrology, mahmutiyilmaz@yahoo.com. 2. Endocrinology. 3. Radiology. 4. Biochemistry, and. 5. Epidemiology, Gulhane School of Medicine, Etlik-Ankara, Turkey; and. 6. Departments of Nephrology. 7. Nephrology, Hypertension and Renal Transplantation and National Research Council-Institute of Clinical Physiology Clinical Epidemiology of Renal Diseases and Hypertension, Ospedali Riuniti, Reggio Calabria, Italy. 8. National Research Council-Institute of Clinical Physiology Clinical Epidemiology of Renal Diseases and Hypertension, Ospedali Riuniti, Reggio Calabria, Italy.
Abstract
BACKGROUND AND OBJECTIVES: The role of reversibility of nontraditional risk factors, like inflammation and CKD-mineral bone disorder, in the reduction of cardiovascular risk after renal transplantation is still scarcely defined. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: The longitudinal relationship between C-reactive protein, CKD-mineral bone disorder biomarkers, and intima media thickness was investigated in a series of 178 patients (age=32±10 years) with stage 5 CKD maintained on chronic dialysis who underwent echo-color Doppler studies of the carotid arteries before and after renal transplantation. Smokers and patients with diabetes were excluded from the study. In all patients, immunosuppression was performed by a standard regimen on the basis of calcineurin inhibitors. Healthy controls were specifically selected to match the age and sex distribution of the patients. Biochemical and intima media thickness assessments were repeated 6 months after transplantation. RESULTS: Before transplantation, intima media thickness in patients with stage 5 CKD on dialysis (average=0.9±0.2 mm) was higher (P<0.001) than in well matched healthy controls (0.6±0.1 mm) and reduced substantially (-22%; 95% confidence interval, -24% to -20%) after transplantation (P=0.001). GFR (multivariable-adjusted β=0.23; P<0.001), C-reactive protein (β=0.15; P<0.001), and fibroblast growth factor 23 (β=0.28; P<0.001) were the strongest independent correlates of intima media thickness before transplantation. Similarly, longitudinal changes in the same biomarkers were the sole independent correlates of simultaneous changes in intima media thickness (C-reactive protein: β=0.25; fibroblast growth factor 23: β=0.26; P<0.001 for both) after renal transplantation. The evolution of intima media thickness after transplantation was largely independent of classic risk factors, including BP, LDL cholesterol, and insulin resistance, as measured by homeostatic model assessment. CONCLUSIONS: Intima media thickness improves after renal transplantation. Such an improvement associates with parallel changes in serum C-reactive protein and fibroblast growth factor 23. These observations are in keeping with the hypothesis that the decline in cardiovascular risk after transplantation, in part, depends on partial resolution of nontraditional cardiovascular risk factors, like inflammation and CKD-mineral bone disorder.
BACKGROUND AND OBJECTIVES: The role of reversibility of nontraditional risk factors, like inflammation and CKD-mineral bone disorder, in the reduction of cardiovascular risk after renal transplantation is still scarcely defined. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: The longitudinal relationship between C-reactive protein, CKD-mineral bone disorder biomarkers, and intima media thickness was investigated in a series of 178 patients (age=32±10 years) with stage 5 CKD maintained on chronic dialysis who underwent echo-color Doppler studies of the carotid arteries before and after renal transplantation. Smokers and patients with diabetes were excluded from the study. In all patients, immunosuppression was performed by a standard regimen on the basis of calcineurin inhibitors. Healthy controls were specifically selected to match the age and sex distribution of the patients. Biochemical and intima media thickness assessments were repeated 6 months after transplantation. RESULTS: Before transplantation, intima media thickness in patients with stage 5 CKD on dialysis (average=0.9±0.2 mm) was higher (P<0.001) than in well matched healthy controls (0.6±0.1 mm) and reduced substantially (-22%; 95% confidence interval, -24% to -20%) after transplantation (P=0.001). GFR (multivariable-adjusted β=0.23; P<0.001), C-reactive protein (β=0.15; P<0.001), and fibroblast growth factor 23 (β=0.28; P<0.001) were the strongest independent correlates of intima media thickness before transplantation. Similarly, longitudinal changes in the same biomarkers were the sole independent correlates of simultaneous changes in intima media thickness (C-reactive protein: β=0.25; fibroblast growth factor 23: β=0.26; P<0.001 for both) after renal transplantation. The evolution of intima media thickness after transplantation was largely independent of classic risk factors, including BP, LDL cholesterol, and insulin resistance, as measured by homeostatic model assessment. CONCLUSIONS: Intima media thickness improves after renal transplantation. Such an improvement associates with parallel changes in serum C-reactive protein and fibroblast growth factor 23. These observations are in keeping with the hypothesis that the decline in cardiovascular risk after transplantation, in part, depends on partial resolution of nontraditional cardiovascular risk factors, like inflammation and CKD-mineral bone disorder.
Authors: Francesco Antonio Benedetto; Francesca Mallamaci; Giovanni Tripepi; Carmine Zoccali Journal: J Am Soc Nephrol Date: 2001-11 Impact factor: 10.121
Authors: Gérard M London; Alain P Guérin; Francis H Verbeke; Bruno Pannier; Pierre Boutouyrie; Sylvain J Marchais; Fabien Mëtivier Journal: J Am Soc Nephrol Date: 2007-01-03 Impact factor: 10.121
Authors: Edith M Simmons; Anthony Langone; M Tugrul Sezer; John P Vella; Peter Recupero; Jason D Morrow; T Alp Ikizler; Jonathan Himmelfarb Journal: Transplantation Date: 2005-04-27 Impact factor: 4.939
Authors: P C van Dijk; K J Jager; F de Charro; F Collart; R Cornet; F W Dekker; C Grönhagen-Riska; R Kramar; T Leivestad; K Simpson; J D Briggs Journal: Nephrol Dial Transplant Date: 2001-06 Impact factor: 5.992
Authors: Peter Stenvinkel; Christoph Wanner; Thomas Metzger; Olof Heimbürger; Francesca Mallamaci; Giovanni Tripepi; Lorenzo Malatino; Carmine Zoccali Journal: Kidney Int Date: 2002-11 Impact factor: 10.612
Authors: Herwig-Ulf Meier-Kriesche; Jesse D Schold; Titte R Srinivas; Alan Reed; Bruce Kaplan Journal: Am J Transplant Date: 2004-10 Impact factor: 8.086
Authors: Maja Dodig Novaković; Sanja Lovrić Kojundžić; Mislav Radić; Marijana Vučković; Andrea Gelemanović; Marija Roguljić; Katja Kovačević; Josip Orešković; Josipa Radić Journal: J Pers Med Date: 2022-06-16
Authors: Michael E Seifert; Isa F Ashoor; Myra L Chiang; Aftab S Chishti; Dennis J Dietzen; Debbie S Gipson; Halima S Janjua; David T Selewski; Keith A Hruska Journal: Pediatr Transplant Date: 2016-02-15
Authors: Andre L Silva; Daniéliso R Fusco; Hong S Nga; Henrique M Takase; Ariane M Bravin; Mariana M Contti; Mariana F Valiatti; Luis Gustavo M de Andrade Journal: Clin Kidney J Date: 2018-06-06
Authors: Sibel Gulcicek; Carmine Zoccali; Deniz Çebi Olgun; Giovanni Tripepi; Selma Alagoz; Serkan Feyyaz Yalın; Sinan Trabulus; Mehmet R Altiparmak; Nurhan Seyahi Journal: Cardiorenal Med Date: 2017-07-13 Impact factor: 2.041
Authors: Alexandre Karras; Pierre Boutouyrie; Marie Briet; Erwan Bozec; Jean-Philippe Haymann; Christophe Legendre; Lawrence P McMahon; Michel Delahousse Journal: J Am Heart Assoc Date: 2017-09-09 Impact factor: 5.501